Publications (48) Pedro Javier Barroso Chinea publications

filter_list

2023

  1. Drastic decline in vasoactive intestinal peptide expression in the suprachiasmatic nucleus in obese mice on a long-term high-fat diet

    Brain Research Bulletin, Vol. 202

  2. Expression of RAD9B in the mesostriatal system of rats and humans: Overexpression in a 6-OHDA rat model of Parkinson's disease

    Annals of Anatomy, Vol. 250

  3. Morphological study of neuropeptide Y expression in human and mouse anterior insular cortex: Overexpression in the insular cortex and nucleus accumbens in obese mice on a long-term obesogenic diet

    Annals of Anatomy, Vol. 250

2022

  1. Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease

    Molecular and Cellular Neuroscience, Vol. 118

2021

  1. Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism

    Pharmacological Research, Vol. 165

2020

  1. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis

    Autophagy, Vol. 16, Núm. 7, pp. 1279-1295

2018

  1. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease

    Experimental Neurology, Vol. 299, pp. 137-147

2016

  1. A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses

    Molecular Therapy - Methods and Clinical Development, Vol. 3, pp. 16027

  2. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system

    Neurobiology of Disease, Vol. 88, pp. 44-54

2015

  1. D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly

    Neurobiology of Disease, Vol. 78, pp. 77-87

  2. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake

    Neurobiology of Disease, Vol. 74, pp. 325-335

2014

  1. Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons

    Frontiers in Neuroanatomy, Vol. 8, Núm. AUG

2012

  1. Cannabinoid receptors CB 1 and CB 2 form functional heteromers in brain

    Journal of Biological Chemistry, Vol. 287, Núm. 25, pp. 20851-20865

  2. L-DOPA impairs proteasome activity in parkinsonism through D 1 dopamine receptor

    Journal of Neuroscience, Vol. 32, Núm. 2, pp. 681-691

2011

  1. Endogenous morphine-like compound immunoreactivity increases in parkinsonism

    Brain, Vol. 134, Núm. 8, pp. 2321-2338

  2. Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 97-104

  3. Glutamatergic and cholinergic pedunculopontine neurons innervate the thalamic parafascicular nucleus in rats: Changes following experimental parkinsonism

    Brain Structure and Function, Vol. 216, Núm. 4, pp. 319-330

  4. Pallidothalamic-projecting neurons in Macaca fascicularis co-express GABAergic and glutamatergic markers as seen in control, MPTP-treated and dyskinetic monkeys

    Brain Structure and Function, Vol. 216, Núm. 4, pp. 371-386

2010

  1. A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys

    Neurobiology of Disease, Vol. 39, Núm. 3, pp. 381-392

  2. Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia

    Frontiers in Neuroanatomy